A. O. Ordine Mauriziano di Torino
In research, A. O. Ordine Mauriziano di Torino stands highest in Medicine (#4,571 of 10,443 worldwide) and Health Sciences (#5,923 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 8.4× its share of world research.
- World rank, 2022–2025
- #14,378 of 28,054 · #17,694 all time
- Rank in Italy
- #422 of 618
- Research works
- 1.1k ▲ 79% vs 2013–17
- Citations
- 18k 16.6 per fractional work
- Top-10% rate
- 11.9% record average 16.5%
- Open access
- 39% world 28%
What is A. O. Ordine Mauriziano di Torino known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,571 of 10,443 | 12.0% | 185 | #6226 | |
| Health SciencesDomain | #5,923 of 11,982 | 11.9% | 195 | #8177 |
Each strip is that field’s whole ranked pool, with the notch where A. O. Ordine Mauriziano di Torino sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does A. O. Ordine Mauriziano di Torino specialise in?
Where its research is concentrated relative to its size: Oncology takes 8.4× the share of its output that it takes of world research.
- OncologySubfield · 21.9 works8.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.
- Medicine 4.2×
- Immunology and Microbiology 1.9×
- Dentistry 1.6×
- Health Professions 1.2×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Economics, Econometrics and Finance 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.7×
- Mathematics 0.4×
- Nursing 0.4×
- Arts and Humanities 0.3×
- Physics and Astronomy 0.2×
- Psychology 0.2×
- Neuroscience 0.1×
- Social Sciences 0.1×
- Computer Science 0.1×
- Engineering 0.1×
- Decision Sciences 0.1×
- Business, Management and Accounting 0.1×
- Agricultural and Biological Sciences 0.0×
- Chemistry 0.0×
- Energy 0.0×
- Environmental Science 0.0×
- Materials Science 0.0×
Who are the top researchers at A. O. Ordine Mauriziano di Torino?
Ranked on the composite score, Marco Daperno, Lorenzo Capussotti and Rodolfo Rocca lead among researchers whose main affiliation is A. O. Ordine Mauriziano di Torino.
- 1 Marco Daperno Italy · #54,053 worldwide 229 citations · 48 works
- 2 Lorenzo Capussotti Italy · #58,643 worldwide 149 citations · 43 works
- 3 Rodolfo Rocca Italy · #101,260 worldwide 203 citations · 28 works
- 4 Annamaria Ferrero Italy · #110,775 worldwide 144 citations · 82 works
- 5 A. Pera Italy · #143,986 worldwide 197 citations · 21 works
- 6 Emanuele Meliga Italy · #145,468 worldwide 658 citations · 19 works
- 7 Guglielmo Mario Actis Dato Italy · #154,127 worldwide 173 citations · 27 works
- 8 Martino Marangella Italy · #191,368 worldwide 82 citations · 36 works
- 9 Maurilio Deandrea Italy · #255,290 worldwide 113 citations · 19 works
- 10 R. Sostegni Italy · #269,569 worldwide 210 citations · 16 works
Which keywords describe research at A. O. Ordine Mauriziano di Torino?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Treatment, Clinical Practice Guidelines, Chemotherapy, Epidemiology, Diagnosis, Clinical Trials, Management and Hepatocellular Carcinoma.
- Robotic Surgery
- Total Hip Replacement
- Pancreatic Cancer
- Health-related Quality of Life
- Tumor Models
- Fallopian Tube Origin
- Genomic Analysis
- Survival Analysis
- Tumor Microenvironment
- Liver Cancer
- Survival
- Complications
- Prognostic Factors
- Guidelines
- Quality of Life
- Biomarkers
- Inflammation
- Clinical Trials
- Chemotherapy
- Treatment
- Epidemiology
- Clinical Practice Guidelines
- Diagnosis
- Management
- Hepatocellular Carcinoma
- Immunotherapy
- Neoadjuvant Therapy
- Metastasis
- Radiofrequency Ablation
- Echocardiography
- Genetic Mutations
- Sorafenib
- Ovarian Cancer
- Autoantibodies
- Cytoreductive Surgery
- Mutation Analysis
- Cardiac Imaging
- Surgical Management
- Revision Surgery
- Molecular Characterization
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology26▲ 2.8×70 topics
- Treatment19▲ 6.8×25 topics
- Clinical Practice Guidelines18▲ 14×13 topics
- Chemotherapy17▲ 11×19 topics
- Diagnosis16▲ 7.5×25 topics
- Clinical Trials14▲ 9.1×13 topics
- Management12▲ 6.7×20 topics
- Inflammation12▲ 2.5×42 topics
- Hepatocellular Carcinoma10▲ 21×3 topics
- Biomarkers10▲ 6.2×13 topics
- Immunotherapy10▲ 5.9×15 topics
- Quality of Life10▲ 2.9×25 topics
- Neoadjuvant Therapy8▲ 16×5 topics
- Guidelines8▲ 7.2×11 topics
- Metastasis8▲ 9.9×5 topics
- Prognostic Factors8▲ 7.4×10 topics
- Radiofrequency Ablation8▲ 31×2 topics
- Complications7▲ 6.2×13 topics
- Echocardiography7▲ 12×7 topics
- Survival7▲ 23×3 topics
- Genetic Mutations7▲ 7.1×16 topics
- Liver Cancer7▲ 55×1 topic
- Sorafenib7▲ 55×1 topic
- Tumor Microenvironment7▲ 6.9×8 topics
- Ovarian Cancer6▲ 32×3 topics
- Survival Analysis6▲ 10×6 topics
- Autoantibodies6▲ 11×7 topics
- Genomic Analysis6▲ 11×4 topics
- Cytoreductive Surgery6▲ 39×2 topics
- Fallopian Tube Origin6▲ 55×1 topic
- Mutation Analysis6▲ 34×2 topics
- Tumor Models6▲ 42×2 topics
- Cardiac Imaging5▲ 18×3 topics
- Health-related Quality of Life5▲ 9.3×5 topics
- Surgical Management5▲ 5.3×8 topics
- Pancreatic Cancer5▲ 19×3 topics
- Revision Surgery5▲ 16×2 topics
- Total Hip Replacement5▲ 16×2 topics
- Molecular Characterization4▲ 10×5 topics
- Robotic Surgery4▲ 13×5 topics
Which research topics does A. O. Ordine Mauriziano di Torino publish most on?
By volume in 2022–2025: Hepatocellular Carcinoma Treatment and Prognosis, Ovarian cancer diagnosis and treatment, Pancreatic and Hepatic Oncology Research and Cardiac Valve Diseases and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 7 works
- 2 Ovarian cancer diagnosis and treatment Reproductive Medicine 6 works
- 3 Pancreatic and Hepatic Oncology Research Oncology 4 works
- 4 Cardiac Valve Diseases and Treatments Cardiology and Cardiovascular Medicine 4 works
- 5 Colorectal Cancer Surgical Treatments Oncology 3 works
- 6 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 3 works
- 7 Liver Disease Diagnosis and Treatment Epidemiology 3 works
- 8 Systemic Lupus Erythematosus Research Rheumatology 3 works
- 9 Lipoproteins and Cardiovascular Health Surgery 3 works
- 10 Total Knee Arthroplasty Outcomes Surgery 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has A. O. Ordine Mauriziano di Torino's research output changed?
Output in 2018–2022 was 79% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Turin
- University of Turin
- Politecnico di Torino
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino
- Istituto Nazionale di Ricerca Metrologica
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
- Tecnologie Avanzate (Italy)
- Azienda Ospedaliero Universitaria San Giovanni Battista
- CTO Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.